Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections

Microbial Pathogenesis

Volumn 34, Issue 1, 2003, Pages 11-16

  Hogan, Richard J ^a   Mathews, Sarah A ^a   Kutlin, Andrei ^b   Hammerschlag, Margaret R ^b   Timms, Peter ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Chlamydia pneumoniae; Continuous infection; Gene expression; Membrane protein; Persistence; Real time RT PCR

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE PROTEIN;

ACUTE DISEASE; ARTICLE; BACTERIAL CELL; BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL MEMBRANE; BACTERIAL METABOLISM; BACTERIUM CULTURE; CELL DIVISION; CELL INCLUSION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC CODE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

CHLAMYDIA; CHLAMYDIA PNEUMONIAE; CHLAMYDOPHILA PNEUMONIAE;

EID: 0037216312     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(02)00187-0     Document Type: Article

References (37)

1. Schachter J. Chlamydial infections. N Engl J Med. 298:1978;428-435.
2. Brunham R.C., Maclean I.W., Binns B., Peeling R.W. Chlamydia trachomatis: its role in tubal infertility. J Infect Dis. 152:1985;1275-1282.
3. Rahman M.U., Cheema M.A., Schumacher H.R. Jr., Hudson A.P. Molecular evidence for the presence of Chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum. 35:1992;521-529.
4. Kuo C.C., Jackson L.A., Campbell L.A., Grayston J.T. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev. 8:1995;451-461.
5. Saikku P., Leinonen M., Mattila K., Ekman M.-R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet, ii. 1988;983-986.
6. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 350:1997;430-436.
7. Holland S.M., Hudson A.P., Bobo L., Whittum-Hudson J.A., Viscidi R.P., Quinn T.C., Taylor H.R. Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect Immun. 60:1992;2040-2047.
8. Nanagara R., Li F., Beutler A., Hudson A., Schumacher H.R. Jr. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes: suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 38:1995;1410-1417.
9. Somani J., Bhullar V.B., Workowski K.A., Farshy C.E., Black C.M. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis. 181:2000;1421-1427.
10. Gérard H.C., Branigan P.J., Schumacher H.R. Jr., Hudson A.P. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J Rheumatol. 25:1998;734-742.
11. Gérard H.C., Freise J., Wang Z., Roberts G., Rudy D., Krauß-Opatz B., Köhler L., Zeidler H., Schumacher H.R., Whittum-Hudson J.A., Hudson A.P. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect. 4:2002;13-22.
12. Yang Y.S., Kuo C.C., Chen W.J. Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect Immun. 39:1983;655-658.
13. Malinverni R., Kuo C.C., Campbell L.A., Grayston J.T. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J Infect Dis. 172:1995;593-594.
14. Koehler L., Nettelnbreker E., Hudson A.P., Ott N., Gérard H.C., Branigan P.J., Schumacher H.R., Drommer W., Zeidler H. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb Pathog. 22:1997;133-142.
15. Matsumoto A., Manire G.P. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J Bacteriol. 101:1970;278-285.
16. Kutlin A., Roblin P.M., Hammerschlag M.R. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob Agents Chemother. 43:1999;2268-2272.
17. Mathews S., George C., Flegg C., Stenzel D., Timms P. Differential expression of ompA, ompB, pyk, nlpD and CPn0585 genes between normal and interferon-γ treated cultures of Chlamydia pneumoniae. Microb Pathog. 30:2001;337-345.
18. Beatty W.L., Morrison R.P., Byrne G.I. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect Immun. 63:1995;199-205.
19. Summersgill J.T., Sahney N.N., Gaydos C.A., Quinn T.C., Ramirez J.A. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect Immun. 63:1995;2801-2803.
20. Beatty W.L., Byrne G.I., Morrison R.P. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA. 90:1993;3998-4002.
21. Dreses-Werringloer U., Padubrin I., Jürgens-Saathoff B., Hudson A.P., Zeidler H., Köhler L. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob Agents Chemother. 44:2000;3288-3297.
22. Wolf K., Fischer E., Hackstadt T. Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun. 68:2000;2379-2385.
23. Coles A.M., Reynolds D.J., Harper A., Devitt A., Pearce J.H. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydial pathogenesis? FEMS Microbiol Lett. 106:1993;193-200.
24. Hsia R.C., Ohayon H., Gounon P., Dautry-Varsat A., Bavoil P.M. Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain Guinea Pig Inclusion Conjunctivitis. Microbes Infect. 2:2000;761-772.
25. Airenne S., Surcel H.M., Alakärppä H., Laitinen K., Paavonen J., Saikku P., Laurila A. Chlamydia pneumoniae infection in human monocytes. Infect Immun. 67:1999;1445-1449.
26. Moulder J.W., Levy N.J., Schulman L.P. Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form. Infect Immun. 30:1980;874-883.
27. Lee C.K., Moulder J.W. Persistent infection of mouse fibroblasts (McCoy cells) with a trachoma strain of Chlamydia trachomatis. Infect Immun. 32:1981;822-829.
28. Kutlin A., Roblin P.M., Hammerschlag M.R. Effect of prolonged treatment with azithromycin, clarithromycin and levofloxacin on Chlamydia pneumoniae in a continuous infection model. Antimicrob Agents Chemother. 46:2002;409-412.
29. Kutlin A., Roblin P.M., Hammerschlag M.R. Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model. J Antimicrob Chemother. 49:2002;763-767.
30. Jones M.L., Gaston J.S.H., Pearce J.H. Induction of abnormal Chlamydia trachomatis by exposure to interferon-γ or amino acid deprivation and comparative antigenic analysis. Microb Pathog. 30:2001;299-309.
31. Byrne G.I., Ouellette S.P., Wang Z., Rao J.P., Lu L., Beatty W.L., Hudson A.P. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect Immun. 69:2001;5423-5429.
32. Molestina R.E., Klein J.B., Miller R.D., Pierce W.H., Ramirez J.A., Summersgill J.T. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect Immun. 70:2002;2976-2981.
33. Kutlin A., Flegg C., Stenzel D., Reznik T., Roblin P.M., Mathews S., Timms P., Hammerschlag M.R. Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J Clin Microbiol. 39:2001;3721-3723.
34. Kubo A., Stephens R.S. Characterization and functional analysis of PorB, a Chlamydia porin and neutralizing target. Mol Microbiol. 38:2000;772-780.
35. Kubo A., Stephens R.S. Substrate-specific diffusion of select dicarboxylates through Chlamydia trachomatis PorB. Microbiology. 147:2001;3135-3140.
36. Lenz D.C., Lu L., Conant S.B., Wdf N.A., Gérard H.C., Whittum-Hudson J.A., Hudson A.P., Swanborg R.H. A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats. J Immunol. 167:2001;1803-1808.
37. Kalman S., Mitchell W., Marathe R., Lammel C., Fan J., Hyman R.W., Olinger L., Grimwood J., Davis R.W., Stephens R.S. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat Genet. 21:1999;385-389.